Comprehensive analysis of HE4 expression in normal and malignant human tissues. - Wikidata - awgldk - TriplyDB

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

http://www.wikidata.org/entity/Q30440200

about

Human epididymis protein-4 (HE-4): a novel cross-class protease inhibitor Lung cancer signatures in plasma based on proteome profiling of mouse tumor models HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Current clinical application of serum biomarkers to detect ovarian cancer The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.Plasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.A mouse to human search for plasma proteome changes associated with pancreatic tumor development.Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS.Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis.Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.RNA-Seq quantification of the human small airway epithelium transcriptome Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.Biomarkers in uterine leiomyoma Quantifying the expression of tumor marker genes in lung squamous cell cancer with RNA sequencing.HE4 as a biomarker for ovarian and endometrial cancer management.HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition.Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women Expression and diagnostic value of HE4 in pancreatic adenocarcinoma.Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms.Human epididymis protein 4 reference limits and natural variation in a Nordic reference population Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma.Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance.Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma

P2860

Q24303274-3CE1C18E-51C4-4DF1-A747-5176790EFD2C Q24628852-4864B62A-3596-4AD2-AB96-069223B855F7 Q24634978-4D76E45F-176E-49B9-B59C-A1D4E9CCC525 Q24651331-9777BE85-521F-4506-8750-C94FECEBE805 Q26768709-0E435898-552A-45C2-AAAF-0B8BDCC7AA6A Q26992102-5851D925-9E05-4465-A1D0-3ADD89AF8312 Q30414041-1C5DBBF6-4B9B-4715-A38B-04E4965DAC4B Q30430198-CDDA4475-4E4A-4E0B-8F79-FD294E15315E Q30434977-5451478C-E384-40A4-8E52-7CB55A027CC6 Q32173966-D56C65EF-EE58-4C3D-8ADA-C87318B28E5F Q33343004-EA15D808-6156-446A-A26D-94F16B6C7A93 Q33503319-218E732F-908F-4F99-90C1-EE353E15D94E Q33574039-29E18E43-1898-40B0-A142-EF8B0843A963 Q33624809-1A7D68E5-6592-4192-9BB5-C9C2D00F1E7E Q33653799-42E87A21-D4AC-4FA6-AF9C-D83221B280D5 Q33729850-95D1AC25-60E5-4713-B0DA-75C0626B868E Q33733786-2485CDB6-CCAA-4EDA-A299-36B3A97F025C Q34178271-8807FB1D-8973-401F-8AC0-6C6A2A8EBEBD Q34308808-E079EB55-92EF-4C27-BCE7-9DB99BF428DD Q34364766-36927E74-4657-4881-83E2-15C37E765C20 Q34406190-17F26346-66E1-4EB1-AA17-1037D75072B0 Q34430598-385BE1F1-6EC5-428E-A7B5-3C9A347FCE19 Q34611530-FD8F3387-BD0F-4E54-BE6D-C807E5C399DA Q34621826-4559DF03-5AE2-4EE5-BA8D-F3AA35DCC70F Q34983422-7E42E28F-3705-4A4B-B2CF-0EB31562B776 Q35006871-78051C68-95C0-463D-AD62-3E7DC4B1D0D5 Q35017292-68EC6A3A-76AA-4BF1-9610-CF5F0E69A551 Q35021181-1453390A-ADD8-43DA-A4A1-280217D0B512 Q35126762-49325CA7-6C0A-4BBD-AF91-5B6FD96AD9B2 Q35138972-BC562789-CAB4-4D89-8B30-8E613EA344E9 Q35166076-C90336AA-4965-4E07-8F73-2628A8BD5CEB Q35605987-AB35109E-D023-4789-B862-B3FCA04433FC Q35648196-3E325D7E-7878-489A-BEBC-A91E7BC8C27B Q35688448-8EBF7016-F662-4FC8-BE1A-EABC24E1DB54 Q35759059-9976ADA7-AA30-403C-AA4F-DE00B3D13094 Q35812813-FD5E3FAC-AFCF-45ED-BDAE-C912067C4586 Q36053925-3E8C9B73-62B9-407B-95D2-E1D3EC0F4D57 Q36226142-E4A1B3E4-B419-48F3-BEB7-9447D1448E7B Q36286844-8D77BB1F-4E4D-470D-8129-77BEB46D57F8 Q36430125-FEE8962D-B221-4DCA-B597-2529B022FB5E

P2860

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

http://www.wikidata.org/entity/Q30440200

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@ast

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@en

type

label

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@ast

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@en

prefLabel

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@ast

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@en

P1433

Q30440200-9E20D83C-8221-4C9D-88F5-C6943F222D02

P1476

Q30440200-7CF0DD98-DD37-43DF-BF37-31905097A43D

P2093

Q30440200-5ADA1145-930E-4D21-831B-0AD1A0AE130A

Q30440200-9F19A8BC-81D9-44E5-BE6B-F8B7B7F62B5D

Q30440200-C2A05C00-8E8D-4E12-966B-41BAE28B9CDD

P2860

Q30440200-33E74A81-3C93-4B4B-BBC1-ACA8C9F1A38C

Q30440200-42F9FC16-89CC-4A0A-AF92-664211D23FC0

Q30440200-5895935B-CD08-439B-87C4-EE433628257A

Q30440200-6AD80813-E8E8-48D7-8274-75BC28387E8B

Q30440200-6EA81ECA-A0C9-4CCC-8362-60238556AABB

Q30440200-741D0300-78E7-4EBB-80DB-760E7DC66419

Q30440200-7F40344E-8D31-443C-AA41-A4E72262EAE1

Q30440200-804372E9-604D-4A3A-A442-DC718121BEBC

Q30440200-8416ABB6-5643-4C90-BF2A-E9645C448F00

Q30440200-8BF7B73A-78B6-4D36-8863-9D501FC5A59B

P2888

Q30440200-C9F81155-EF91-4CA5-8176-077BEF0356E0

P304

Q30440200-2909E3D0-E125-41F9-A4C9-9539F0821002

P31

Q30440200-63147092-95B1-4DBC-9763-81E535B425F1

P356

Q30440200-C87657ED-2AE6-41DB-9360-01475A3862BF

P433

Q30440200-CC70B98B-A9FB-4AF2-8A60-AC3FFA3FCDA4

P478

Q30440200-7256D7A2-583E-4A53-9F8C-801E4D382CAF

P577

Q30440200-DBD997F6-42B2-4FD8-A657-6496E9CA0FBD

P5875

Q30440200-D6A8C966-DBC4-42B0-934C-8F05D286727C

P6179

Q30440200-0737943E-F790-4A70-AF65-69F0DC7A49BE

P698

Q30440200-07635E47-70E5-46BF-A872-20DA9B636AD4

P356

MODPATHOL.3800612

P1433

Modern Pathology

P1476

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

@en

P2093

Garret M Hampton

http://www.w3.org/2001/XMLSchema#string

Henry F Frierson

http://www.w3.org/2001/XMLSchema#string

Mary T Galgano

http://www.w3.org/2001/XMLSchema#string

P2860

A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase

A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein

Gene expression patterns in ovarian carcinomas

The evolution of a genetic locus encoding small serine proteinase inhibitors

Expression monitoring by hybridization to high-density oligonucleotide arrays

Molecular characterization of epididymal proteins

Large-scale analysis of the human and mouse transcriptomes.

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.

P2888

modpathol.3800612

P304

847-853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.3800612

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7173352

http://www.w3.org/2001/XMLSchema#string

P6179

1009362937

http://www.w3.org/2001/XMLSchema#string

P698

16607372

http://www.w3.org/2001/XMLSchema#string